JuE Wong Named CEO of StriVectin®, Melisse Shaban Elevated to Chairman

NEW YORK, July 12, 2012 /PRNewswire/ -- StriVectin®, the world's largest, independent, prestige, anti-aging skin care brand, today announced that Melisse Shaban has been elevated to Chairman and JuE Wong has been appointed Chief Executive Officer, effective July 10, 2012. "StriVectin's growth surge continues on the back of our clinically proven, unique technology," Ms. Shaban said. "We are on a tear---and we needed to enhance our leadership team to support this growth.  We intend to continue to delight and surprise our consumers and provide unrivalled support to our retail partners.  We are thrilled to have JuE's unique skills to take us to the next level."

(Photo: http://photos.prnewswire.com/prnh/20120712/NY39096 )

Ms. Wong joins StriVectin following a long and successful career in the beauty industry.  Most recently, she served as Chief Executive Officer of Astral Health & Beauty, which achieved meaningful growth through product innovations and expansion of global distribution under her leadership.  Prior to Astral, Ms. Wong held senior leadership positions at ZO Skin Health by Dr. Obagi, N.V. Perricone M.D. Cosmeceuticals, and Murad, Inc., all of which achieved exceptional growth during her tenure.  Ms. Wong received a B.A. with Honors from The Australian National University and has served on the Boards of the American Heart Association and the Atlanta Chapter of the YMCA.

"JuE's international experience and direct channel experience will be invaluable in our next phase of growth," Ms. Shaban said.  "The reformulation of the StriVectin line with the breakthrough proprietary NIA 114™ technology is now complete.  Women around the world are enjoying the benefits of younger looking skin through cellular level molecular regeneration---we are truly making the world younger looking and more beautiful, one face at a time.  We are incredibly fortunate to have JuE's proven leadership skills to help us grow this revolution, in an industry that has traditionally offered more hope than results.  In my continuing role as Chairman, I will focus more heavily on strategy and technological innovation." 

"I am pleased to join the talented team at StriVectin and share their confidence in StriVectin's continued growth and product innovation opportunities," said Ms. Wong.  "StriVectin's reputation as a leader in scientific innovation is evident in its proprietary NIA-114™ technology, rooted in over 30 years of research into DNA repair and skin cancer prevention.  In recognition of this dedication to technology, StriVectin has been awarded numerous industry accolades, including the 'Skin Sense Award' by The Skin Cancer Foundation and '2012 Winner - Prestige Moisturizer' by Cosmetic Executive Women.  In joining StriVectin, I see an opportunity to build on these successes by continuing to launch technologically innovative products and further strengthen our retail partnerships across the globe."

About StriVectin®

StriVectin® is the largest, independent, prestige skin care company, focusing on clinical anti-aging skin care solutions. Backed by science and rigorous clinical validation, StriVectin is at the forefront of skin care technology and product innovation.  Its unique dual-use repair cream StriVectin-SD™  Intensive Concentrate for Stretch Marks and Wrinkles is a best-seller around the world, and is often credited with starting the clinical cosmeceutical skin care category. StriVectin products are sold through department stores and specialty retailers in North America, Europe, the Middle East and Asia. The company is headquartered in New York, NY.  For more information, visit strivectin.com

Contact:              
Lisa Lauri, (646) 251-1713, [email protected]

SOURCE StriVectin